Advertisement
News
Subscribe to MDT Magazine News

Trying brain pacemakers to zap psychiatric disease

February 21, 2011 3:45 am | by LAURAN NEERGAARD - AP Medical Writer - Associated Press | Comments

Call them brain pacemakers, tiny implants that hold promise for fighting tough psychiatric diseases — if scientists can figure out just where in all that gray matter to put them.Deep brain stimulation, or DBS, has proved a powerful way to block the tremors of Parkinson's disease. Blocking...

SuccessEHS Announces its Enterprise Ambulatory EHR Solution for Hospitals

February 21, 2011 3:35 am | by Bio-Medicine.Org | Comments

BIRMINGHAM, Ala., Feb. 21, 2011 /- SuccessEHS, a nationally recognized, streamlined practice management and electronic health record (EHR) vendor, has coupled its premier ambulatory care software solution with a signature Success Architecture to meet the ambulatory care needs of...

TOPICS:

Mater Children's Hospital in Australia Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities

February 21, 2011 3:33 am | by Bio-Medicine.Org | Comments

IRVINE, Calif. and BRISBANE, Australia, Feb. 21, 2011 /- Mater Children's Hospital and Masimo (Nasdaq: MASI ) today jointly announce the conversion of Mater Children's Hospital to Masimo rainbow® SET Pulse CO-Oximetry™ technology for advanced noninvasive patient monitoring...

TOPICS:
Advertisement

A Presidential Pardon on Joint Pain

February 21, 2011 1:35 am | by Bio-Medicine.Org | Comments

BRADENTON, Fla., Feb. 21, 2011 /- Past presidents such as Gerald Ford, Ronald Reagan, and George H.W. Bush are among the millions of Americans who have undergone some form of joint replacement/repair surgery. While we see presidents come and go, advancements in joint replacement...

TOPICS:

Sheffield Bio-Science and Wockhardt Announce Worldwide Exclusive Partnership to Supply Recombinant Insulin to Cell Culture Market

February 21, 2011 1:35 am | by Bio-Medicine.Org | Comments

BELOIT, Wis., Feb. 21, 2011 /- Sheffield Bio-Science, a Kerry Group Business, has formed a strategic global sales, marketing and development alliance with Wockhardt Ltd. Under this partnership, Sheffield Bio-Science will be the Exclusive Global Sales and Distribution Partner for...

TOPICS:

LifeWatch Teams With UnitedHealthcare, The Largest Healthcare Insurer In The United States, As A Preferred National Provider Of Cardiac Monitoring Services To Reduce Patient C...

February 20, 2011 10:34 pm | by Bio-Medicine.Org | Comments

ROSEMONT, Ill., Feb. 21, 2011 /- LifeWatch AG (SIX Swiss Exchange: LIFE) today announces an initiative with UnitedHealthcare Insurance Company, an affiliate of United-Health Group (NYSE: UNH) that will provide members insured by UnitedHealthcare in-network access to LifeWatch cardiac...

TOPICS:

Reprogrammed stem cells hit a roadblock

February 20, 2011 8:37 pm | by EurekAlert | Comments

(Ecole Polytechnique Fédérale de Lausanne) Is there a future for stem cell therapies that don't use embryonic stem cells? An international study involving EPFL has raised doubts, by showing that "reprogramming" adult stem cells leads to genetic aberrations.

TOPICS:

Increasing triglyceride levels linked to greater stroke risk

February 20, 2011 8:34 pm | by EurekAlert | Comments

(Wiley-Blackwell) A study by researchers in Denmark revealed that increasing levels of non-fasting triglycerides are associated with an increased risk of ischemic stroke in men and women. Higher cholesterol levels were associated with greater stroke risk in men only. Details of this...

TOPICS:
Advertisement

New NxStage® FREEDOM Data Shows Continued, Marked Benefits for Patients Using the System One™ for Daily Home Hemodialysis Throughout a 12 Month Period(2)

February 20, 2011 6:35 pm | by Bio-Medicine.Org | Comments

LAWRENCE, Mass. and PHOENIX, Feb. 20, 2011 /- NxStage® Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis products, today announced the latest interim results from its ongoing FREEDOM study which show an increase in overall quality of life benefits,...

TOPICS:

New NxStage® FREEDOM Data Shows Continued, Marked Benefits for Patients Using the System One™ for Daily Home Hemodialysis Throughout a 12 Month Period

February 20, 2011 5:35 pm | Comments

LAWRENCE, Mass. and PHOENIX, Feb. 20, 2011 /- NxStage® Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer of innovative dialysis products, today announced the latest interim results from its ongoing FREEDOM study which show an increase in overall quality of life benefits,...

How to leave your body

February 20, 2011 9:37 am | by EurekAlert | Comments

(Karolinska Institutet) Leave your body and shake hands with yourself, gain an extra limb or change into a robot for a while. Swedish neuroscientist Henrik Ehrsson has demonstrated that the brain's image of the body is negotiable. Applications stretch from touch-sensitive...

TOPICS:

Look after your brain

February 20, 2011 9:37 am | by EurekAlert | Comments

(Karolinska Institutet) As the average life span becomes longer, dementia becomes more common. Swedish scientist Laura Fratiglioni has shown that everyone can minimize his or her risk of being affected. Factors from blood pressure and weight to the degree of physical and mental...

TOPICS:

One Health: From ideas to implementation, rhetoric to reality

February 20, 2011 9:33 am | by EurekAlert | Comments

(American Society for Microbiology) The convergence of people, animals, and our environment has created a new dynamic in which the health of each group is inextricably and globally interconnected, without borders. It is against this background that One Health has emerged as a...

TOPICS:

Family planning programs have success in developing countries, but need to be expanded

February 20, 2011 6:36 am | by EurekAlert | Comments

(Ohio State University) While many researchers generally credit the desire for smaller families for the decline in fertility rates in developing, low-income countries, new research suggests that prevention of unwanted births may actually be a larger factor. The advent of safe and...

TOPICS:

CompanDX Ltd. and Clinical Reference Laboratory, Inc. Sign Multi-Year Deal in Support of Collaborative Gene Signature and Companion Diagnostic Development

February 19, 2011 3:31 am | by Bio-Medicine.Org | Comments

LENEXA, Kan., Feb. 19, 2011 /- CompanDX Ltd., bioinformatics partner for the life sciences industry, and Clinical Reference Laboratory, Inc. (CRL), provider of laboratory testing services in molecular diagnostics and clinical trials, today announced they entered into a multi-year...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading